# Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic Cancer

> **NCT06026943** · NA · RECRUITING · sponsor: **Alpha Tau Medical LTD.** · enrollment: 15 (estimated)

## Conditions studied

- Pancreatic Cancer
- Unresectable Pancreatic Cancer
- Pancreatic Adenocarcinoma

## Interventions

- **DEVICE:** DaRT seeds insertion

## Key facts

- **NCT ID:** NCT06026943
- **Lead sponsor:** Alpha Tau Medical LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-04
- **Primary completion:** 2027-01
- **Final completion:** 2028-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06026943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06026943, "Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06026943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*